• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDINAL HEALTH SANTA CLARA MYNX CONTROL; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDINAL HEALTH SANTA CLARA MYNX CONTROL; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Model Number N/A
Device Problems Entrapment of Device (1212); Decrease in Pressure (1490); Difficult to Remove (1528); Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/17/2023
Event Type  malfunction  
Manufacturer Narrative
The product history review is expected but has not been completed.This device has been analyzed but the final, approved draft of the engineering report and its conclusion is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, closing failed with a 5f mynx control vascular closure device (vcd) because it was ¿coming out of sealant skin¿.There was no reported patient injury.The device will be returned for evaluation.Addendum: product evaluation demonstrated that button two was not completely depressed, approximately 5/6 of its total travel.However, once reset to factory setting, button two was depressed completely and locked in place.The balloon was not able to be retracted completely into the tamp tube.In addition, a leak and a longitudinal tear in the balloon of the returned device was noted.
 
Manufacturer Narrative
After further review of additional information received the following sections have been updated accordingly: g3, g6, h2, h3, h6, and h10 complaint conclusion: as reported, closing failed with a 5f mynx control vascular closure device (vcd) because it was ¿coming out of sealant skin¿.There was no reported patient injury.Multiple attempts to obtain additional information were made without success.A non-sterile ¿mynx control vcd, 5f¿ involved in the reported complaint was returned for investigation.Visual inspection of the device showed that both button 1 and button 2 were depressed with the clock symbol visible in the tension indicator window.It was noted that button 2 was not completely depressed, approximately 5/6 of its total travel.The syringe was received connected to the device for evaluation with the stopcock opened as received.In addition, the balloon was observed not completely retracted into the tamp tube.The sealant was not returned with the device and an unknown cordis procedural sheath was on the device, exposed to blood.The returned device was inspected for damages/anomalies that may have contributed to the reported failure and no damages/anomalies were observed on the returned device.Per functional analysis, button 2 of the returned device was reset to its factory setting, and the balloon¿s inverted tip was straightened out.An inflation/deflation test was simulated, and a leak was found with the balloon of the device.Then, button 2 was depressed completely and locked in place; however, the balloon was not able to be retracting completely into the tamp tube.Visual inspection at high magnification revealed on that the balloon was observed not completely retracted into the tamp tube, and a leak and longitudinal tear in the balloon of the return device was observed.The product history record (phr) review of lot f2224402 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported event of ¿sealant-inaccurate placement-complete¿ was not confirmed since the sealant was not received with the device.Additionally, the events of ¿balloon-balloon loss of pressure¿ and ¿balloon-retraction jam¿ were noted during analysis of the returned device due to the leakage/rupture noted and the issue with balloon retraction.However, the exact cause of the issues experienced could not be conclusively determined during analysis.Based on the limited information for review, it is not possible to determine what factors may have contributed to events reported.However, access site vessel characteristics (although not provided) and/or concomitant device factors most likely contributed to the rupture noted since a calcified vessel and/or concomitant device factors (such as a damaged procedural sheath, stent, or vascular graft) can cause damage to the balloon and the subsequent difficulty retraction difficulty of the balloon.According to the instructions for use (ifu), which is not intended as a mitigation, ¿the safety and effectiveness of the mynx control vcd have not been established in the following patient populations: patients with clinically significant peripheral vascular disease in the vicinity of the puncture.¿ also stated in the ifu, ¿open the stopcock to deflate the balloon.To ensure complete balloon deflation, wait until air bubbles and fluid have stopped moving through the inflation tubing.Pick up the device handle and realign with the tissue tract.Depress button #2 to pull the deflated balloon into the device.¿ additionally, users are instructed to discard the device if the balloon does not maintain pressure.Neither the phr review nor the product analysis suggest that the reported failures could be related to the design or manufacturing process of the unit.Therefore, no corrective/preventative actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNX CONTROL
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CARDINAL HEALTH SANTA CLARA
5452 betsy ross drive
santa clara CA 95054
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
14021 nw 60 avenue
miami lakes, FL 33014
7863138372
MDR Report Key17894641
MDR Text Key325261300
Report Number3004939290-2023-03414
Device Sequence Number1
Product Code MGB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberMX5060E
Device Lot NumberF2224402
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/21/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/15/2023
Initial Date FDA Received10/09/2023
Supplement Dates Manufacturer Received10/09/2023
Supplement Dates FDA Received10/18/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-